We tested the effects of 8CA/8AA on primary AML blasts derived from various R/R AML patients and observed the consistent results that 8CA/8AA inhibit MAT2A expression and histone methylation levels and synergize with VEN to target the viability of AML blast cells (Fig. 4A–D). The gene discussed is MAT2A; the disease is acute myeloid leukemia.